858 Therapeutics Funding & Investors
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response.
8five8tx.comTotal Amount Raised: $105,231,600
858 Therapeutics Funding Rounds
Series Unknown
$25,175,501
Series A
$60,000,000
Series A Investors
Versant VenturesLogos CapitalCormorant Asset ManagementNew Enterprise Associates (NEA)Series Unknown
$20,056,095
Funding info provided by Diffbot.